Skip to content

Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG)

Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00456638
Enrollment
0
Registered
2007-04-05
Start date
2008-04-30
Completion date
2008-04-30
Last updated
2014-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

OP-CABG, Depodur traditional drug

Brief summary

The purpose of this study is to determine whether epidural Depodur alleviates the pain of OP-CABG surgery. This includes pain associated with sternotomy, retraction, dissection and other tissue insults, as well as the induced inflammatory system and effects from prolonged ventilation in the ICU setting.

Detailed description

The purpose of this study is to determine whether epidural Depodur alleviates the pain of OP-CABG surgery. This includes pain associated with sternotomy, retraction, dissection and other tissue insults, as well as the induced inflammatory system and effects from prolonged ventilation in the ICU setting. It will be compared to placebo.

Interventions

Depodur vs. traditional management

Sponsors

Drexel University College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Male or Female, 18-99 years old * All patients who will have surgery for OP-CABG

Exclusion criteria

* Pregnant females * Patients with allergy to morphine * Patients nursing an infant * Patients with migraine headaches * Patients taking Coumadin within 7 days or demonstrating INR \> 13 * Patients taking Heparin unless documented normal partial thromboplastin time * Patients taking Clopidogrel in previous 7 days * Patients taking Ticlopidine in previous 14 days * Patients taking Aspirin in previous 48 hours * Patients receiving low molecular weight heparin therapy within 24 hours previous * Patients with Narcolepsy and/or sleep apnea * Patients on chronic opioid therapy * Patients participating in another study

Design outcomes

Primary

MeasureTime frame
Comparison of pain (Visual Analog Scale), post-op morphine usage, and side effects between the two study groups

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026